Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study

Nephrology Dialysis Transplantation

Volumn 14, Issue 3, 1999, Pages 676-682

  Girndt, Matthias ^b   Heisel, Olaf ^b   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

Biocompatibility; Complement activation; Haemodialysis; Interleukin 10; Monokines

Indexed keywords

CELLULOSE; COMPLEMENT; HEMOPHAN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MONOKINE; POLYAMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0033008725     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.3.676     Document Type: Article

References (24)

1. Girndt M, Köhler H, Schiedhelm Weick E et al. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995; 47: 559-565
2. van Ypersele de Strihou C, Jadoul M, Malghem J et al. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991; 39: 1012-1019
3. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 1992; 60: 56-59
4. Deppisch R, Schmitt V, Bommer J et al. Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int 1990; 37: 696-706
5. Schindler R, Linnenweber S, Schulze M et al. Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993; 43: 712-721
6. Dinarello CA. Cytokines. Agents provocateur in hemodialysis? Kidney Int 1992; 41: 683-694
7. Memoli B, Libetta C, Rampino T et al. Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephrol Dial Transplant 1991; 6 [Supp) 2]: 96-98
8. Honkanen E, Grönhagen-Riska C, Teppo AM et al. Acute-phase proteins during haemodialysis: Correlations with serum interleukin-1 β levels and different dialysis membranes. Nephron 1991; 57: 283-287
9. Canivet E, Lavaud S, Wong T et al. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis 1994; 23: 41-46
10. Daugirdas JT, Ing TS. Handbook of Dialysis. Little, Brown, Boston, 1994
11. Ritz E, Deppisch R, Stier E et al. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 1994; 9 [Suppl 2]: 165-172
12. Pertosa G, Tarantino EA, Gesualdo L et al. C5b-9 generation and cytokine production in hemodialysed patients. Kidney Int Suppl 1993; 41: S221-225
13. Betz M, Haensch GM, Rauterberg EW et al. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int 1988; 34: 67-73
14. Urena P, Herbelin A, Zingraff J et al. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in vitro haemodialysis. Nephrol Dial Transplant 1992; 7: 16-28
15. Herbelin A, Urena P, Man NK et al. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production. Contrib Nephrol 1989; 74 79-85
16. Herbelin A, Nguyen AT, Zingraff J et al. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990; 37: 116-125
17. Pereira BJ, Poutsiaka DD, King AJ et al. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 1992; 42: 1419-1424
18. Herbelin A, Urena P, Nguyen AT et al. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes. Nephrol Dial Transplant 1991; 6: 349-357
19. Herbelin A, Urena P, Nguyen AT et al. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954-960
20. Cavaillon JM, Poignet JL, Fitting C et al. Serum interleukin-6 in long-term hemodialysed patients. Nephron 1992; 60: 307-313
21. Chollet-Martin S, Stamatakis G, Bailly S et al. Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane type. Clin Exp Immunol 1991; 83: 329-332
22. Schindler R, Lonnemann G, Shaldon S et al. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93
23. Fiorentino DF, Zlotnik A, Mosmann TR et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822
24. Köhler H, Arnold W, Renschin G et al. Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 1984; 25: 124-128